Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006 (2006), Article ID 32508, 5 pages
http://dx.doi.org/10.1155/MI/2006/32508
Research Communication

Soluble CD40 Ligand Levels in Otherwise Healthy Subjects With Impaired Fasting Glucose

1Department of Internal Medicine, Gulhane School of Medicine, Etlik, Ankara 06018, Turkey
2Department of Public Health, Gulhane School of Medicine, Etlik, Ankara 06018, Turkey
3Department of Biochemistry, Gulhane School of Medicine, Etlik, Ankara 06018, Turkey

Received 1 June 2006; Accepted 7 August 2006

Copyright © 2006 Ilker Tasci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D W Laight, M J Carrier, and E E Anggard, “Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy,” Diabetes/Metabolism Research and Reviews, vol. 15, no. 4, pp. 274–282, 1999. View at Publisher · View at Google Scholar
  2. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 27, no. suppl 1, pp. S5–S10, 2004. View at Google Scholar
  3. J E Shaw, P Z Zimmet, A M Hodge et al., “Impaired fasting glucose: how low should it go?” Diabetes Care, vol. 23, no. 1, pp. 34–39, 2000. View at Google Scholar
  4. M Hanefeld and T Temelkova-Kurktschiev, “The postprandial state and the risk of atherosclerosis,” Diabetic Medicine, vol. 14, no. suppl 3, pp. S6–S11, 1997. View at Publisher · View at Google Scholar
  5. S H Saydah, M Miret, J Sung, C Varas, D Gause, and F L Brancati, “Postchallenge hyperglycemia and mortality in a national sample of U.S. adults,” Diabetes Care, vol. 24, no. 8, pp. 1397–1402, 2001. View at Google Scholar
  6. S M Haffner, “Pre-diabetes, insulin resistance, inflammation and CVD risk,” Diabetes Research and Clinical Practice, vol. 61, no. suppl 1, pp. S9–S18, 2003. View at Publisher · View at Google Scholar
  7. M Tominaga, H Eguchi, H Manaka, K Igarashi, T Kato, and A Sekikawa, “Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study,” Diabetes Care, vol. 22, no. 6, pp. 920–924, 1999. View at Google Scholar
  8. U Schönbeck and P Libby, “The CD40/CD154 receptor/ligand dyad,” Cellular and Molecular Life Sciences, vol. 58, no. 1, pp. 4–43, 2001. View at Google Scholar
  9. P Aukrust, F Müller, T Ueland et al., “Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes,” Circulation, vol. 100, no. 6, pp. 614–620, 1999. View at Google Scholar
  10. A G Semb, S Van Wissen, T Ueland et al., “Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy,” Journal of the American College of Cardiology, vol. 41, no. 2, pp. 275–279, 2003. View at Publisher · View at Google Scholar
  11. K Gokulakrishnan, R Deepa, V Mohan, and M D Gross, “Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome—the Chennai Urban Rural Epidemiology Study,” Metabolism: Clinical and Experimental, vol. 55, no. 2, pp. 237–242, 2006. View at Publisher · View at Google Scholar
  12. D R Matthews, J P Hosker, A S Rudenski, B A Naylor, D F Treacher, and R C Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar
  13. A Wasunna, A Whitelaw, R Gallimore, P N Hawkins, and M B Pepys, “C-reactive protein and bacterial infection in preterm infants,” European Journal of Pediatrics, vol. 149, no. 6, pp. 424–427, 1990. View at Publisher · View at Google Scholar
  14. R W Simpson, J E Shaw, and P Z Zimmet, “The prevention of type 2 diabetes—lifestyle change or pharmacotherapy? A challenge for the 21st century,” Diabetes Research and Clinical Practice, vol. 59, no. 3, pp. 165–180, 2003. View at Publisher · View at Google Scholar
  15. E A Ashley, V Raxwal, M Finlay, and V Froelicher, “Diagnosing coronary artery disease in diabetic patients,” Diabetes/Metabolism Research and Reviews, vol. 18, no. 3, pp. 201–208, 2002. View at Publisher · View at Google Scholar
  16. DECODE Study Group and the European Diabetes Epidemiology Group, “Glucose tolerance and cardiovascular mortality. Comparison of fasting and 2-hour diagnostic criteria,” Archives of Internal Medicine, vol. 161, no. 3, pp. 397–405, 2001. View at Publisher · View at Google Scholar
  17. P Mohanty, W Hamouda, R Garg, A Aljada, H Ghanim, and P Dandona, “Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 8, pp. 2970–2973, 2000. View at Publisher · View at Google Scholar
  18. A J Jenkins, J D Best, R L Klein, and T J Lyons, “Lipoproteins, glycoxidation and diabetic angiopathy,” Diabetes/Metabolism Research and Reviews, vol. 20, no. 5, pp. 349–368, 2004. View at Publisher · View at Google Scholar
  19. G Basta, A M Schmidt, and R De Caterina, “Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes,” Cardiovascular Research, vol. 63, no. 4, pp. 582–592, 2004. View at Publisher · View at Google Scholar
  20. K Esposito, F Nappo, R Marfella et al., “Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress,” Circulation, vol. 106, no. 16, pp. 2067–2072, 2002. View at Publisher · View at Google Scholar
  21. O A Mojiminiyi, N Abdella, M A Moussa, A O Akanji, H Al Mohammedi, and M Zaki, “Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 58, no. 1, pp. 37–44, 2002. View at Publisher · View at Google Scholar
  22. A Ceriello, C Taboga, L Tonutti et al., “Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment,” Circulation, vol. 106, no. 10, pp. 1211–1218, 2002. View at Publisher · View at Google Scholar
  23. M Hanefeld, C Koehler, E Henkel, K Fuecker, F Schaper, and T Temelkova-Kurktschiev, “Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes,” Diabetic Medicine, vol. 17, no. 12, pp. 835–840, 2000. View at Publisher · View at Google Scholar
  24. D W Laight, M J Carrier, and E E Anggard, “Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy,” Diabetes/Metabolism Research and Reviews, vol. 15, no. 4, pp. 274–282, 1999. View at Publisher · View at Google Scholar
  25. P E Szmitko, C-H Wang, R D Weisel, J R De Almeida, T J Anderson, and S Verma, “New markers of inflammation and endothelial cell activation. Part I,” Circulation, vol. 108, no. 16, pp. 1917–1923, 2003. View at Publisher · View at Google Scholar
  26. R P Phipps, “Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 13, pp. 6930–6932, 2000. View at Publisher · View at Google Scholar
  27. F Cipollone, C Ferri, G Desideri et al., “Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty,” Circulation, vol. 108, no. 22, pp. 2776–2782, 2003. View at Publisher · View at Google Scholar
  28. Y Nishi, M Fukushima, H Suzuki et al., “Insulin secretion and insulin sensitivity in Japanese subjects with impaired fasting glucose and isolated fasting hyperglycemia,” Diabetes Research and Clinical Practice, vol. 70, no. 1, pp. 46–52, 2005. View at Publisher · View at Google Scholar
  29. L-K Chen, M-H Lin, Z-J Chen, S-J Hwang, S-T Tsai, and S-T Chiou, “Metabolic characteristics and insulin resistance of impaired fasting glucose among the middle-aged and elderly Taiwanese,” Diabetes Research and Clinical Practice, vol. 71, no. 2, pp. 170–176, 2006. View at Publisher · View at Google Scholar
  30. E Cersosimo and R A DeFronzo, “Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases,” Diabetes/Metabolism Research and Reviews. In press.
  31. J S Yudkin, C DA Stehouwer, J J Emeis, and S W Coppack, “C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 972–978, 1999. View at Google Scholar
  32. E S Kang, H J Kim, C W Ahn et al., “Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 69, no. 2, pp. 151–159, 2005. View at Publisher · View at Google Scholar
  33. C Snehalatha, V Vijay, R Suresh Mohan et al., “Lack of association of insulin resistance and carotid intimal medial thickness in non-diabetic Asian Indian subjects,” Diabetes/Metabolism Research and Reviews, vol. 17, no. 6, pp. 444–447, 2001. View at Publisher · View at Google Scholar
  34. E Bonora, R Tessari, R Micciolo et al., “Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients: relationship with insulin resistance,” Diabetes Care, vol. 20, no. 4, pp. 627–631, 1997. View at Google Scholar
  35. Y Igarashi, T Mita, R Mizuno et al., “Characteristics of Japanese subjects who progress from normal to impaired glucose tolerance. Longitudinal study excluding changes in body weight,” Endocrine Journal, vol. 52, no. 6, pp. 683–689, 2005. View at Publisher · View at Google Scholar
  36. D J Rader, K Ikewaki, N Duverger et al., “Very low high-density lipoproteins without coronary atherosclerosis,” Lancet, vol. 342, no. 8885, pp. 1455–1458, 1993. View at Publisher · View at Google Scholar
  37. R P Tracy, B M Psaty, E Macy et al., “Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 10, pp. 2167–2176, 1997. View at Google Scholar
  38. P Greenland, M D Knoll, J Stamler et al., “Major risk factors as antecedents of fatal and nonfatal coronary heart disease events,” Journal of the American Medical Association, vol. 290, no. 7, pp. 891–897, 2003. View at Publisher · View at Google Scholar